Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study

dc.creatorPérez-García, Felipe
dc.creatorPérez-Tanoira, Ramón
dc.creatorRomanyk, Juan
dc.creatorArroyo, Teresa
dc.creatorGómez-Herruz, Peña
dc.creatorCuadros-González, Juan
dc.date.accessioned2020-07-27T17:56:28Z
dc.date.accessioned2022-09-23T18:32:48Z
dc.date.available2020-07-27T17:56:28Z
dc.date.available2022-09-23T18:32:48Z
dc.date.created2020-07-27T17:56:28Z
dc.identifier1386-6532
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1386653220302158?via%3Dihub
dc.identifierhttp://hdl.handle.net/20.500.12010/11203
dc.identifierhttps://doi.org/10.1016/j.jcv.2020.104473
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3502907
dc.publisherJournal of Clinical Virology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectInmunoensayo de flujo lateral
dc.subjectPrueba rápida serológica
dc.titleAlltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study


Este ítem pertenece a la siguiente institución